Atsuto Mouri

机构：Saitama International Medical Center, Saitama Medical University · ORCID：0000-0001-8704-8151

发表论文 190 篇 · 总被引 1139 次 · h-index 18

代表论文

Prognostic relevance of TROP2 expression in patients with non-small cell lung cancer receiving immunotherapy (2025 · Scientific Reports · 被引 6)
Lenvatinib for patients with previously treated advanced thymic carcinoma in real-world settings (2025 · ESMO Open · 被引 6)
A Real‐Word Analysis of the Correlation Between Clinical Efficacy and Predictive Factors of Immune‐Related Adverse Events in Patients With Nonsmall Lung Cancer Treated With Nivolumab Plus Ipilimumab (2025 · Cancer Medicine · 被引 4)
Eosinophils as predictive biomarkers in anti-programmed cell death 1 monotherapy for non-small cell lung cancer (2025 · Frontiers in Immunology · 被引 3)
The CD4+ T cell population partners with Tpex CD8+ T cells to mediate antitumor immunity in the tumor microenvironment (2026 · Nature Communications · 被引 2)
Real-world occurrence of severe gastrointestinal bleeding in patients receiving amivantamab plus lazertinib: A two-case series among 25 consecutive cases (2026 · Lung Cancer · 被引 2)